Alexion Pharma quarterly adj profit beats, raises forecast again
October 23, 2014 at 07:18 AM EDT
Oct 23 (Reuters) - Alexion Pharmaceuticals Inc reported a better-than-expected adjusted profit on strong sales of its blood disorder drug Soliris and raised its full-year profit forecast for the fourth time this year.